iBio, Inc. Listing Deficiency Resolved

by Allie Wickman, Benzinga Staff Writer

January 27, 2012 7:02 AM | 11 seconds read | Make a Comment

iBio, Inc.

IBIO

announced today that the NYSE Amex confirmed positive resolution of the Company's previously noted listing deficiency with respect to Section 1003(1)(iv) of the NYSE Amex Company Guide.

Market News and Data brought to you by Benzinga APIs

Posted In: News Legal Markets

Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!

-

-

-

-

-

-

-

-

-

-

-

-

-

-

iBio, Inc. Listing Deficiency Resolved